Физиолошки ефекат статуса гвожђа на пацијенте са синдромом полицистичних јајника у граду Басрах

Статус гвожђа код пацијената са синдромом полицистичних јајника

  • Dalal Alakabi Al-Kunooze University College/ Department of medical laboratory techniques
DOI: https://doi.org/10.5937/jomb0-39091

Sažetak


Синдром полицистичних јајника (ПЦОС) је једно од најчешћих гинеколошких болести које утичу на плодност жена у провинцији Басра. Садашња студија је дизајнирана да процени аберације гвожђа код пацијената са ПЦОС мерењем повезаних параметара и њиховог односа са полним хормонима код пацијената са ПЦОС. Узорци серума су прикупљени од 45 пацијената са ПЦОС-ом и 45 контрола из приватне женске клинике и мерени су ЕЛИСА тестом у приватној медицинској лабораторији. Резултати су показали значајно смањење нивоа хепцидина, трансферина и естрадиола наспрам значајног повећања гвожђа, феритина, прогестерона и тестостерона. Садашња студија је показала јасну неравнотежу у нивоу гвожђа и његових серумских регулационих параметара код жена са ПЦОС-ом, и постоји ефикасна корелација између статуса гвожђа и полних хормона.

Reference

1. Louwers, Y. V., & Laven, J. S. (2020). Characteristics of polycystic ovary syndrome throughout life. Therapeutic Advances in Reproductive Health, 14, 2633494120911038.
2. Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F.,... & Nouri, H. R. (2021). Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome. Journal of Cellular Physiology, 236(2), 824-838.
3. Bednarska, S., & Siejka, A. (2017). The pathogenesis and treatment of polycystic ovary syndrome: What’s new. Adv Clin Exp Med, 26(2), 359-367.
4. Gökcen, B. B., Akdevelioğlu, Y., Canan, S., & Bozkurt, N. (2021). Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 26(5), 1581-1593. .‏
5. Adamska, A., Łebkowska, A., Krentowska, A., Adamski, M., & Kowalska, I. (2020). The association between serum ferritin concentration and visceral adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome. Frontiers in endocrinology, 10, 873. ‏
6. Escobar-Morreale, H. F. (2012). Iron metabolism and the polycystic ovary syndrome. Trends in Endocrinology & Metabolism, 23(10), 509-515.
7. Rashidi, B. H., Shams, S., Shariat, M., Bagheri, M., Mohebi, M., & Haghollahi, F. (2018). The association of serum hepcidin levels and insulin resistance in PCOS Patients: A case-control study. Journal of family & reproductive health, 12(4), 210.
8. Luque-Ramírez, M., Álvarez-Blasco, F., Alpañés, M., & Escobar-Morreale, H. F. (2011). Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. The journal of clinical endocrinology & metabolism, 96(3), 846-852.
9. Xu, Y., Alfaro‐Magallanes, V. M., & Babitt, J. L. (2021). Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders. British Journal of Haematology, 193(5), 882-893.
10. Barba-Moreno, L., Alfaro-Magallanes, V., Calderón, F., & Peinado, A. (2020). Systemic iron homeostasis in female athletes: Hepcidin, exercise and sex influence. Arch. Med. Deport, 37, 348-353.
11. Kali, A., Charles, M. V. P., & Seetharam, R. S. K. (2015). Hepcidin-A novel biomarker with changing trends. Pharmacognosy reviews, 9(17), 35.
12. Guo, W., Bachman, E., Li, M., Roy, C. N., Blusztajn, J., Wong, S.,... & Bhasin, S. (2013). Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging cell, 12(2), 280-291.
13. Roth, M. P., Meynard, D., & Coppin, H. (2019). Regulators of hepcidin expression. Vitamins and hormones, 110, 101-129.
14. Alfaro Magallanes, V. M., Barba Moreno, L., & Peinado, A. B. (2021). Ferritin status impact on hepcidin response to endurance exercise in physically active women along different phases of the menstrual cycle. Arch. med. deporte, 22-27. .‏
15. Li X, Rhee DK, Malhotra R, Mayeur C, Hurst L, Ager E, et al. Progesterone receptor membrane component-1 regulates hepcidin biosynthesis. J Clin Invest. 2016;126:389–401.
16. McClung J, Karl P. Iron deficiency and obesity: The contribution of inflammation and diminished iron absorption. Nutr Rev. 2009;67.
17. Bachman, E., Travison, T. G., Basaria, S., Davda, M. N., Guo, W., Li, M.,... & Bhasin, S. (2014). Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 69(6), 725-735. ‏
18. Bajbouj, K., Shafarin, J., Allam, H., Madkour, M., Awadallah, S., El-Serafy, A.,... & Hamad, M. (2018). Elevated levels of estrogen suppress hepcidin synthesis and enhance serum iron availability in premenopausal women. Experimental and Clinical Endocrinology & Diabetes, 126(07), 453-459.
19. Lehtihet, M., Bonde, Y., Beckman, L., Berinder, K., Hoybye, C., Rudling, M.,... & Angelin, B. (2016). Circulating hepcidin-25 is reduced by endogenous estrogen in humans. PLoS One, 11(2), e0148802.
20. Yang, Q., Jian, J., Katz, S., Abramson, S. B., & Huang, X. (2012). 17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology, 153(7), 3170-3178. ‏
21. Begum, T., Ishra, S., Sharifa, B. S., Nahar, S., Begum, H. A., Khan, S. S., & Khanum, M. (2021). Association of serum ferritin with insulin resistance in women with polycystic ovarian syndrome. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10(8), 2924-2932. ‏
22. Luque-Ramírez, M., Álvarez-Blasco, F., Botella-Carretero, J. I., Sanchón, R., San Millán, J. L., & Escobar-Morreale, H. F. (2007). Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care, 30(9), 2309-2313. ‏
23. De Jong, G., Van Dijk, J. P., & Van Eijk, H. G. (1990). The biology of transferrin. Clinica chimica acta, 190(1-2), 1-46.
24. M., Abdel Hafez; A., El Shehaby; S.S., Alwakil; M., Rizk; A.F., Albigawy.. (2008). Circulating soluble transferrin receptor and ferritin in polycystic ovary syndrome: 241-254.
25. Yang, J. H., Chou, C. H., Yang, W. S., Ho, H. N., Yang, Y. S., & Chen, M. J. (2015). Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome. Taiwanese journal of obstetrics and gynecology, 54(6), 686-692.
Objavljeno
2022/09/09
Broj časopisa
Vol. 42 Br. 3 (2023): Journal of Medical Biochemistry
Rubrika
Original paper

Sva prava zadržana (c) 2022 Dalal Alakabi

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.